JPRN-UMIN000003027已完成2 期
Phase II clinical trial of personalized peptide vaccination for Renal cell carcinoma patients - Peptide vaccination for Renal cell carcinoma patients
Kurume University Cancer Vaccine Center0 个研究点目标入组 100 人开始时间: 2010年1月13日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The following patients must be excluded. 1) Patients with severe symptoms (active and severe infectious disease, circulatory disease, respiratory disease, kidney disease, immunodeficiency, disturbance of coagulation). 2) Patients with the past history of severe allergic reactions. "3) (Females) Patients who are during pregnancy, lactation expectant, and desiring future fertility. (Males) Patients do not accept contraception during the 1st vaccination to 70 days after the last vaccination." 4) Patients who are judged inappropriate for the clinical trial by doctors.
研究者
相似试验
已完成
2 期
Phase II clinical trial of personalized peptide vaccination in patients with advanced/metastatic urotherial cancer previously treated with M-VAC chemotherapyrotherial cancerJPRN-UMIN000001061Kurume University School of medicine, Department of Immunology20
已完成
2 期
Phase II clinical trial of personalized peptide vaccination for standard therapy failure patients with malignant glioma (glioblastoma)malignant glioma (glioblastoma)JPRN-UMIN000001243Department of Immunology, Kurume University School of medicine40
已完成
2 期
Phase II clinical trial of personalized peptide vaccination for decetaxel no indicated patients with hormone-refractory prostate cancerProstate cancerJPRN-UMIN000001242Kurume University Research Center for Innovative Cancer Therapy, Clinical Research Division55
已完成
2 期
Phase II clinical trial of personalized peptide vaccination for standard chemotherapy failed scirrhous gastric cancer patientsScirrhous gastric cancerJPRN-UMIN000001883Kurume University Cancer Vaccine Center100
已完成
2 期
Phase II clinical trial of personalized peptide vaccination for standard therapy failed Biliary cancer(Cholangiocell carcinoma,Gallbladder cancer and Biliary tract cancer) patientsBiliary cancer (Cholangiocell carcinoma,Gallbladder cancer and Biliary tract cancer)JPRN-UMIN000001884Kurume University Cancer Vaccine Center100